Evidence map›Paper›PMID 36016682›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Untargeted Metabolomics Analysis of

Raheleh Shakeri, Bahram Savari, Mahsa N Sheikholeslami, Tayebeh Radjabian, Jalal Khorshidi, Maliheh Safavi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Plant Metabolomics: The Future of Anticancer Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Raheleh ShakeriDepartment of Biological Science and Biotechnology, Faculty of Science, University of Kurdistan, Sanandaj, Iran.ORCID https://orcid.org/0000-0002-1048-1472
Bahram SavariDepartment of Biological Science and Biotechnology, Faculty of Science, University of Kurdistan, Sanandaj, Iran.ORCID https://orcid.org/0000-0003-3119-7873
Mahsa N SheikholeslamiCenter of Excellence in Electrochemistry, Faculty of Chemistry, University of Tehran, Tehran 1417614418, Iran.ORCID https://orcid.org/0000-0001-8254-3153
Tayebeh RadjabianImmunoregulation Research Center, Shahed University, Tehran, Iran.ORCID https://orcid.org/0000-0001-8280-9409
Jalal KhorshidiDepartment of Horticultural Science and Engineering, Research Center of Medicinal Plants Breeding and Development, University of Kurdistan, Sanandaj, Iran.ORCID https://orcid.org/0000-0001-8082-7697
Maliheh SafaviDepartment of Biotechnology, Iranian Research Organization for Science and Technology, Tehran 13353-5111, Iran.ORCID https://orcid.org/0000-0003-0950-3141
University of Kurdistan · IRIranian Research Organization for Science and Technology · IRShahed University · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Safranal, crocin, crocetin, and picrocrocin are major known compounds in the stigma extract of

Identifiers

PMID36016682
PMCPMC9398734
OpenAlexW4293498772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.